Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Bilateral vitelliform maculopathy and deferoxamine toxicity.

× No keyword cloud information.

8 in total

1. Macular vitelliform lesion in desferrioxamine-related retinopathy.

Authors: Mohamed A Genead; Gerald A Fishman; Anastasios Anastasakis; Martin Lindeman
Journal: Doc Ophthalmol Date: 2010-06-09 Impact factor: 2.379

2. Rapid development of severe toxic retinopathy associated with continuous intravenous deferoxamine infusion.

Authors: T Y Y Lai; G K Y Lee; W-M Chan; D S C Lam
Journal: Br J Ophthalmol Date: 2006-02 Impact factor: 4.638

Review 3. Ocular abnormalities in beta thalassemia patients: prevalence, impact, and management strategies.

Authors: Samira Heydarian; Reza Jafari; Kiumars Nowroozpoor Dailami; Hassan Hashemi; Ebrahim Jafarzadehpour; Mohsen Heirani; Abbasali Yekta; Monireh Mahjoob; Mehdi Khabazkhoob
Journal: Int Ophthalmol Date: 2019-10-10 Impact factor: 2.031

4. Pseudovitelliform maculopathy associated with deferoxamine toxicity: multimodal imaging and electrophysiology of a rare entity.

Authors: Kelly M Bui; SriniVas R Sadda; Hani Salehi-Had
Journal: Digit J Ophthalmol Date: 2017-02-13

5. Efficacy of brinzolamide ophthalmic suspension 1% for treatment of a vitelliform macular lesion in a patient with desferrioxamine retinopathy.

Authors: Mohamed A Genead; Gerald A Fishman
Journal: Ophthalmic Surg Lasers Imaging Date: 2011-12-08

Bilateral vitelliform maculopathy and deferoxamine toxicity.

1. Macular vitelliform lesion in desferrioxamine-related retinopathy.

2. Rapid development of severe toxic retinopathy associated with continuous intravenous deferoxamine infusion.

Review 3. Ocular abnormalities in beta thalassemia patients: prevalence, impact, and management strategies.

4. Pseudovitelliform maculopathy associated with deferoxamine toxicity: multimodal imaging and electrophysiology of a rare entity.

5. Efficacy of brinzolamide ophthalmic suspension 1% for treatment of a vitelliform macular lesion in a patient with desferrioxamine retinopathy.

6. Multimodal imaging in a case of deferoxamine-induced maculopathy.

Review 7. Functional and Structural Abnormalities in Deferoxamine Retinopathy: A Review of the Literature.

8. Pattern dystrophies in patients treated with deferoxamine: report of two cases and review of the literature.